eduKateSG · Why Science?
Describe where a tumour arose and what it is—without confusing a registry classification with stage, prognosis, treatment or a complete pathology diagnosis
Choose the closest route, then return to the full index whenever you need the wider evidence chain.
Science learning becomes powerful when students can tell a measured pattern from a model, a statistical decision from a mechanism, and a useful lead from a finished conclusion. The International Classification of Diseases for Oncology is used principally by tumour and cancer registries to code the site and histology of neoplasms. On 20 July 2026, the International Agency for Research on Cancer announced that final ICD-O-4 tables were available. ICD-O-4 adds a new morphology structure with five-digit morphology codes based on the fifth edition of the WHO Classification of Tumours, alongside updated morphology and topography lists and explicit change tables from ICD-O-3.2. Classification supports comparable registry data, but a code does not replace the pathology report, determine stage or treatment, predict outcome or prove that records from different editions can be combined without reviewed migration. This guide supports Primary Science, PSLE Science, Secondary Science, O-Level Science and STEM education as a longform evidence-reading route; it is not medical advice, a laboratory protocol, an admission promise or a career guarantee.
Related eduKate reading: ICD-11 and comparable health classification; MeSH and reproducible biomedical search; OMOP CDM and reproducible observational-health research; careers by subject capability; Science Learning Hub; Education Hub; STEM Education; Careers by Subject Capability.
Primary and official sources checked on 13 October 2026: IARC announcement of final ICD-O-4 tables, published 20 July 2026 and checked 13 October 2026; WHO Classification of Tumours Online ICD-O-4 background and tables, checked 13 October 2026; WHO official ICD-O-3 classification page describing the established multi-axial purpose and revision history, checked 13 October 2026; IARC overview of ICD-O-4, checked 13 October 2026; 2026 Singapore–Cambridge O-Level Biology syllabus; MOE G2/G3 Lower Secondary Science teaching and learning syllabus; 2026 MOE G2 Computing syllabus. Standards, terminologies, classifications and recommendations can change, so preserve dated documentation, exact source data and software versions.
A deeper reading route
Cancer surveillance needs two core descriptions: where a tumour arose and what kind of tumour it is. A site-only classification can group very different diseases together, while a morphology-only label loses the organ context. ICD-O uses multiple axes so registries can preserve both topography and tumour morphology in a structured, comparable record.
ICD-O-4 responds to the evolving WHO Classification of Tumours. IARC explains that new tumour types from the fifth-edition Blue Books increasingly appear in pathology reporting and clinical practice, so the registry classification needed to follow. This is a reminder that classifications are maintained scientific instruments, not permanent tables.
The fourth edition introduces a new morphology structure. Its five-digit morphology codes use a fifth digit that can be zero or another alphanumeric value for more-specific coding. The design aims to preserve continuity where possible while greatly increasing the number of unique morphology codes available for contemporary tumour entities.
Topography and morphology still answer different questions. Topography describes anatomical site; morphology captures the histological or tumour entity concept. Behaviour, grade, stage, laterality and other registry variables are related but not interchangeable. A complete case record keeps each dimension in its proper field and edition.
Change tables are central to responsible migration. The official ICD-O-4 release provides new, changed and deleted morphology codes and terms, behaviour-code changes, and updated topography information relative to ICD-O-3.2. A mapping can be one-to-one, one-to-many, conditional or impossible without reviewing the original diagnosis.
Historical comparability sometimes requires two views. A registry may preserve the original code assigned under the contemporary edition while deriving a harmonised research grouping. The derived value should never overwrite the source code, and the mapping algorithm, review status and unresolved records should travel with every dataset.
Pathology wording remains authoritative context. A code may summarise a recognised entity, yet the source report contains diagnostic qualifiers, molecular findings, site details and uncertainty that influence registration. Automation can propose candidates but should surface ambiguous or edition-sensitive cases for trained review.
Cancer incidence statistics depend on more than classification. Case ascertainment, multiple-primary rules, reportability, death-certificate handling, population denominators and registry completeness all affect rates. ICD-O supports consistency in what is counted; it does not guarantee that every relevant case was captured.
Privacy risks are high because rare tumour types, age, geography and dates can identify a person. Publishing a well-coded table therefore requires aggregation, cell suppression or controlled access as appropriate. A classification makes data easier to analyse, not automatically safe to disclose.
For students, ICD-O-4 offers an optimistic lesson about scientific revision. Better evidence can refine categories without erasing history, provided researchers record editions, publish mappings and keep the original observations available for re-evaluation.
A registry quality programme should test impossible or unusual site–morphology combinations, missing behaviour, sex- or age-sensitive rules and edition validity. Flags support review; they are not automatic proof that a rare record is wrong.
Tumour grade and stage are different constructs. Grade generally concerns cellular differentiation or related tumour characteristics, while stage concerns extent of disease. Neither can be inferred safely from a bare morphology code.
The primary site may be uncertain or unknown. For metastatic disease, the site where a specimen was taken is not necessarily the tumour’s origin. Coding should follow registry rules and documented evidence rather than the convenience of one location field.
Multiple primaries demand governed rules. Two tumours in one organ can represent one disease process or distinct primaries depending on morphology, timing and registry conventions. Row counts are therefore not automatically person counts or primary-cancer counts.
Five-digit detail improves specificity only when the source evidence supports it. Choosing the most detailed available code from a lookup table without matching the pathology statement creates false precision.
Crosswalks to ICD-11 or national billing systems are purpose-specific. A valid registry mapping may not preserve the detail needed for reimbursement, clinical care or research cohort definition. Publish the intended use and known loss.
Machine-learning studies can inherit changes in classification as label drift. Training on ICD-O-3.2 and evaluating on ICD-O-4 data requires a documented label policy, otherwise performance differences may reflect taxonomy rather than biology.
Public dashboards should name edition, diagnosis years, registry coverage and suppression policy. Without those facts, neat comparisons can conceal changes in coding practice or case ascertainment.
| Stage | Question | Evidence | Responsible output |
|---|---|---|---|
| Observe | What does the source pathology and clinical record say? | Diagnosis, site, specimen, dates and uncertainty | A traceable source account |
| Classify | Which ICD-O-4 dimensions apply? | Topography, morphology, behaviour and supported detail | A versioned registry record |
| Harmonise | How are historical editions compared? | Change tables, mapping rules and manual review | A documented research view |
| Interpret | What can the registry statistic support? | Case rules, coverage, denominator and privacy review | A bounded cancer-surveillance claim |
Inside this guide
1–12 · Foundations and design
- 1. Start with the registry question
- 2. Use the current fourth edition
- 3. Preserve the pathology source
- 4. Separate topography from morphology
- 5. Read the updated topography list
- 6. Read the five-digit morphology structure
- 7. Understand the fifth digit
- 8. Keep behaviour explicit
- 9. Keep grade separate
- 10. Keep stage separate
- 11. Resolve primary site carefully
- 12. Represent unknowns honestly
13–24 · Models and estimation
- 13. Use change tables directly
- 14. Expect one-to-many migration
- 15. Expect behaviour changes
- 16. Preserve original edition and code
- 17. Validate site–morphology pairs
- 18. Apply multiple-primary rules
- 19. Separate case from person
- 20. Measure registry completeness
- 21. Use population denominators correctly
- 22. Connect ICD-O-4 to ICD-11
- 23. Connect to pathology standards
- 24. Protect rare-case privacy
25–36 · Diagnostics and interpretation
- 25. Audit automation
- 26. Interpret trends cautiously
- 27. Preserve provenance
- 28. Connect to Primary Science
- 29. Connect to Secondary Science
- 30. Connect to mathematics
- 31. Connect to computing
- 32. Connect to pathways
- 33. Did you know?
- 34. Write a reader-ready methods note
- 35. Build a validation ladder
- 36. Finish with a reproducible bundle
Section 1 of 36
1. Start with the registry question
Define whether the task is case registration, incidence surveillance, historical harmonisation or research cohort creation.
Working checkpoint — ICD-O-4: Write the purpose, diagnosis period and governing registry rules. Keep pathology wording, topography, morphology, behaviour, edition, coder, change-table mapping and validation together.
For a classroom model, sort fictional cards by site and morphology on separate axes.
Section 2 of 36
2. Use the current fourth edition
IARC published final ICD-O-4 tables on 20 July 2026.
Working checkpoint — cancer registry: Record ICD-O-4 and the table release used. Read every registry record beside primary site, specimen, diagnosis date, grade, stage, multiple-primary rule and case source.
For future study, connect cell biology to pathology and public health while checking pathways separately.
Section 3 of 36
3. Preserve the pathology source
The classification summarises evidence from reports; it does not replace the source diagnosis and qualifiers.
Working checkpoint — topography code: Link each code to the authorised source record. Preserve original ICD-O codes and derived harmonisations; migration is not historical replacement.
For writing, cite ICD-O edition, source diagnosis, case rules, mapping and denominator.
Section 4 of 36
4. Separate topography from morphology
Topography describes anatomical site while morphology represents tumour type or histology.
Working checkpoint — morphology code: Validate each axis independently before combining them. Separate classification validity from diagnosis, completeness, prognosis, treatment and causal explanation.
For students, ask why a tumour needs both where and what descriptions.
Section 5 of 36
5. Read the updated topography list
ICD-O-4 provides updated topography codes and terms, including optional added detail for selected sites.
Working checkpoint — tumour behaviour: Use extra specificity only when evidence and registry policy support it. Treat edition, site, morphology, behaviour and case rules as scientific inputs: one change can alter incidence.
For parents, ask whether a cancer statistic states classification edition, period and registry coverage.
Section 6 of 36
6. Read the five-digit morphology structure
ICD-O-4 introduces five-digit morphology codes based on the fifth edition of the WHO Classification of Tumours.
Working checkpoint — WHO Classification of Tumours: Treat the full code as a versioned identifier. Keep pathology wording, topography, morphology, behaviour, edition, coder, change-table mapping and validation together.
For a classroom model, sort fictional cards by site and morphology on separate axes.
Section 7 of 36
7. Understand the fifth digit
The fifth morphology digit may be zero or another alphanumeric value to distinguish more-specific entities.
Working checkpoint — ICD-O-4: Do not truncate a code before checking whether detail is meaningful. Read every registry record beside primary site, specimen, diagnosis date, grade, stage, multiple-primary rule and case source.
For future study, connect cell biology to pathology and public health while checking pathways separately.
Section 8 of 36
8. Keep behaviour explicit
Behaviour is a distinct classification dimension concerning whether a neoplasm is benign, in situ, malignant or otherwise classified under the rules.
Working checkpoint — cancer registry: Never infer behaviour from the organ name alone. Preserve original ICD-O codes and derived harmonisations; migration is not historical replacement.
For writing, cite ICD-O edition, source diagnosis, case rules, mapping and denominator.
Section 9 of 36
9. Keep grade separate
Histologic grade or differentiation is related to morphology but remains a separate data element.
Working checkpoint — topography code: Use the appropriate source and coding rule. Separate classification validity from diagnosis, completeness, prognosis, treatment and causal explanation.
For students, ask why a tumour needs both where and what descriptions.
Section 10 of 36
10. Keep stage separate
Stage describes extent of disease and uses other governed systems and variables.
Working checkpoint — morphology code: Do not present morphology as a stage value. Treat edition, site, morphology, behaviour and case rules as scientific inputs: one change can alter incidence.
For parents, ask whether a cancer statistic states classification edition, period and registry coverage.
Section 11 of 36
11. Resolve primary site carefully
The specimen site, metastatic site and primary site can differ.
Working checkpoint — tumour behaviour: Follow evidence and registry rules for tumour origin. Keep pathology wording, topography, morphology, behaviour, edition, coder, change-table mapping and validation together.
For a classroom model, sort fictional cards by site and morphology on separate axes.
Section 12 of 36
12. Represent unknowns honestly
An unknown primary or insufficiently specified morphology is an evidence state, not a software failure to be filled with a guess.
Working checkpoint — WHO Classification of Tumours: Use the proper unknown category and retain uncertainty. Read every registry record beside primary site, specimen, diagnosis date, grade, stage, multiple-primary rule and case source.
For future study, connect cell biology to pathology and public health while checking pathways separately.
Section 13 of 36
13. Use change tables directly
The release lists new, changed and deleted morphology and topography terms and codes relative to ICD-O-3.2.
Working checkpoint — ICD-O-4: Build migration from official change documentation. Preserve original ICD-O codes and derived harmonisations; migration is not historical replacement.
For writing, cite ICD-O edition, source diagnosis, case rules, mapping and denominator.
Section 14 of 36
14. Expect one-to-many migration
A former category can split into several newer entities that need source detail to distinguish.
Working checkpoint — cancer registry: Flag records that cannot be mapped automatically. Separate classification validity from diagnosis, completeness, prognosis, treatment and causal explanation.
For students, ask why a tumour needs both where and what descriptions.
Section 15 of 36
15. Expect behaviour changes
The official change material includes behaviour-code changes.
Working checkpoint — topography code: Review analyses whose inclusion criteria depend on behaviour. Treat edition, site, morphology, behaviour and case rules as scientific inputs: one change can alter incidence.
For parents, ask whether a cancer statistic states classification edition, period and registry coverage.
Section 16 of 36
16. Preserve original edition and code
Historical registration reflects the terminology available at the time.
Working checkpoint — morphology code: Store source edition, source code and derived harmonised value. Keep pathology wording, topography, morphology, behaviour, edition, coder, change-table mapping and validation together.
For a classroom model, sort fictional cards by site and morphology on separate axes.
Section 17 of 36
17. Validate site–morphology pairs
Some combinations are implausible or require review, although rare biology remains possible.
Working checkpoint — tumour behaviour: Use quality rules as flags, not silent deletion. Read every registry record beside primary site, specimen, diagnosis date, grade, stage, multiple-primary rule and case source.
For future study, connect cell biology to pathology and public health while checking pathways separately.
Section 18 of 36
18. Apply multiple-primary rules
One person can have more than one reportable primary, while repeated records can concern one tumour.
Working checkpoint — WHO Classification of Tumours: State the rule set before counting cases. Preserve original ICD-O codes and derived harmonisations; migration is not historical replacement.
For writing, cite ICD-O edition, source diagnosis, case rules, mapping and denominator.
Section 19 of 36
19. Separate case from person
Registry records, primary tumours and unique people can have different totals.
Working checkpoint — ICD-O-4: Label every denominator and unit of analysis. Separate classification validity from diagnosis, completeness, prognosis, treatment and causal explanation.
For students, ask why a tumour needs both where and what descriptions.
Section 20 of 36
20. Measure registry completeness
Comparable codes cannot repair missing hospitals, delayed notifications or incomplete ascertainment.
Working checkpoint — cancer registry: Report coverage and data-quality indicators. Treat edition, site, morphology, behaviour and case rules as scientific inputs: one change can alter incidence.
For parents, ask whether a cancer statistic states classification edition, period and registry coverage.
Section 21 of 36
21. Use population denominators correctly
Incidence rates require appropriate population counts, calendar periods and age structure.
Working checkpoint — topography code: Publish denominator source and standardisation method. Keep pathology wording, topography, morphology, behaviour, edition, coder, change-table mapping and validation together.
For a classroom model, sort fictional cards by site and morphology on separate axes.
Section 22 of 36
22. Connect ICD-O-4 to ICD-11
ICD-11 and ICD-O support related but different classification tasks and levels of detail.
Working checkpoint — morphology code: Use reviewed correspondence for the stated purpose. Read every registry record beside primary site, specimen, diagnosis date, grade, stage, multiple-primary rule and case source.
For future study, connect cell biology to pathology and public health while checking pathways separately.
Section 23 of 36
23. Connect to pathology standards
WHO tumour classifications inform contemporary entity definitions, while registry coding operationalises those concepts for surveillance.
Working checkpoint — tumour behaviour: Record diagnostic edition and classification edition separately. Preserve original ICD-O codes and derived harmonisations; migration is not historical replacement.
For writing, cite ICD-O edition, source diagnosis, case rules, mapping and denominator.
Section 24 of 36
24. Protect rare-case privacy
Specific morphology, geography, age and dates can identify a person.
Working checkpoint — WHO Classification of Tumours: Aggregate, suppress or control access as required. Separate classification validity from diagnosis, completeness, prognosis, treatment and causal explanation.
For students, ask why a tumour needs both where and what descriptions.
Section 25 of 36
25. Audit automation
Automated suggestions should show matched text, candidate codes, confidence, edition and reason for human review.
Working checkpoint — ICD-O-4: Retain rejected candidates and final coder decision. Treat edition, site, morphology, behaviour and case rules as scientific inputs: one change can alter incidence.
For parents, ask whether a cancer statistic states classification edition, period and registry coverage.
Section 26 of 36
26. Interpret trends cautiously
A rate can change because biology, diagnosis, access, reporting, rules or classification changed.
Working checkpoint — cancer registry: Test these alternatives before causal language. Keep pathology wording, topography, morphology, behaviour, edition, coder, change-table mapping and validation together.
For a classroom model, sort fictional cards by site and morphology on separate axes.
Section 27 of 36
27. Preserve provenance
A reusable registry row links source diagnosis, coding edition, coder, mapping history, case rules and validation.
Working checkpoint — topography code: Make each published count reconstructable. Read every registry record beside primary site, specimen, diagnosis date, grade, stage, multiple-primary rule and case source.
For future study, connect cell biology to pathology and public health while checking pathways separately.
Section 28 of 36
28. Connect to Primary Science
A fictional fictional tumour registry card helps pupils separate an observation from the standardised name or code used to organise it.
Working checkpoint — morphology code: Use invented examples and never use personal health information. Preserve original ICD-O codes and derived harmonisations; migration is not historical replacement.
For writing, cite ICD-O edition, source diagnosis, case rules, mapping and denominator.
Section 29 of 36
29. Connect to Secondary Science
ICD-O-4 supports lessons about classification, evidence, systems, uncertainty and responsible comparison.
Working checkpoint — tumour behaviour: Trace one coded statement back to its observable evidence. Separate classification validity from diagnosis, completeness, prognosis, treatment and causal explanation.
For students, ask why a tumour needs both where and what descriptions.
Section 30 of 36
30. Connect to mathematics
Sets, hierarchies, identifiers, denominators and versioned mappings show why definitions must be fixed before quantities are compared.
Working checkpoint — WHO Classification of Tumours: Work through one small boundary case by hand. Treat edition, site, morphology, behaviour and case rules as scientific inputs: one change can alter incidence.
For parents, ask whether a cancer statistic states classification edition, period and registry coverage.
Section 31 of 36
31. Connect to computing
Versioned code tables, crosswalks, validation rules and audit trails show how software supports cancer surveillance without replacing pathology expertise.
Working checkpoint — ICD-O-4: Break one identifier, release, relationship or mapping, then validate and repair it transparently. Keep pathology wording, topography, morphology, behaviour, edition, coder, change-table mapping and validation together.
For a classroom model, sort fictional cards by site and morphology on separate axes.
Section 32 of 36
32. Connect to pathways
ICD-O-4 connects cell biology, pathology, epidemiology, statistics, public health and data engineering and can illuminate STEM education and career pathways.
Working checkpoint — cancer registry: Check current official education and qualification routes separately from this conceptual guide. Read every registry record beside primary site, specimen, diagnosis date, grade, stage, multiple-primary rule and case source.
For future study, connect cell biology to pathology and public health while checking pathways separately.
Section 33 of 36
33. Did you know?
ICD-O-4 introduced a new five-digit morphology structure so newer tumour entities can receive more-specific codes while continuity is preserved where possible.
Working checkpoint — topography code: Explain the fact in plain language, then name what it does not prove. Preserve original ICD-O codes and derived harmonisations; migration is not historical replacement.
For writing, cite ICD-O edition, source diagnosis, case rules, mapping and denominator.
Section 34 of 36
34. Write a reader-ready methods note
State the standard and release, source data, coding or mapping method, validation, privacy controls and supported claim.
Working checkpoint — morphology code: Keep the note beside the machine-readable record. Separate classification validity from diagnosis, completeness, prognosis, treatment and causal explanation.
For students, ask why a tumour needs both where and what descriptions.
Section 35 of 36
35. Build a validation ladder
Check identifiers, release, syntax, hierarchy, source fidelity, scientific plausibility, privacy and known fixtures in sequence.
Working checkpoint — tumour behaviour: Stop at the earliest unresolved layer. Treat edition, site, morphology, behaviour and case rules as scientific inputs: one change can alter incidence.
For parents, ask whether a cancer statistic states classification edition, period and registry coverage.
Section 36 of 36
36. Finish with a reproducible bundle
Deliver source receipts, releases, mappings, software versions, tests, hashes and limitations without exposing governed health data.
Working checkpoint — WHO Classification of Tumours: Make every published claim traceable. Keep pathology wording, topography, morphology, behaviour, edition, coder, change-table mapping and validation together.
For a classroom model, sort fictional cards by site and morphology on separate axes.
Contents · Previous section · Continue to the Science Learning Hub